FDA Leaves Global Harmonization Working Party, Will Focus International Harmonization Efforts

Three years after joining, the US FDA announced its withdrawal from the Global Harmonization Working Party and intention to focus its work on medical device harmonization through its collaboration with the International Medical Device Regulators Forum.

EXIT SIGN
• Source: Shutterstock

The US Food and Drug Administration announced Monday that it is leaving the Global Harmonization Working Party (GHWP), which the agency joined in 2021.

The FDA also said it would concentrate its efforts to advance global harmonization of medical devices by primarily working with the International Medical Device Regulators Forum (IMDRF).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation